Dougan M - Search Results

1

Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract.

Dougan M. Dougan M. Front Immunol. 2017 Nov 15;8:1547. doi: 10.3389/fimmu.2017.01547. eCollection 2017. Front Immunol. 2017. PMID: 29230210 Free PMC article. Review.

2

Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade.

Reynolds K, Thomas M, Dougan M. Reynolds K, et al. Among authors: dougan m. Oncologist. 2018 Sep;23(9):991-997. doi: 10.1634/theoncologist.2018-0174. Epub 2018 May 31. Oncologist. 2018. PMID: 29853659 Free PMC article.

3

Zhang ML, Neyaz A, Patil D, Chen J, Dougan M, Deshpande V. Zhang ML, et al. Among authors: dougan m. Histopathology. 2020 Jan;76(2):233-243. doi: 10.1111/his.13963. Epub 2019 Nov 13. Histopathology. 2020. PMID: 31361907 Free PMC article.

4

Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events.

Badran YR, Cohen JV, Brastianos PK, Parikh AR, Hong TS, Dougan M. Badran YR, et al. Among authors: dougan m. J Immunother Cancer. 2019 Aug 22;7(1):226. doi: 10.1186/s40425-019-0711-0. J Immunother Cancer. 2019. PMID: 31439050 Free PMC article.

5

Checkpoint blockade toxicities: Insights into autoimmunity and treatment.

Walsh MJ, Dougan M. Walsh MJ, et al. Among authors: dougan m. Semin Immunol. 2021 Feb;52:101473. doi: 10.1016/j.smim.2021.101473. Epub 2021 Mar 14. Semin Immunol. 2021. PMID: 33726931 Review.

6

Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together.

Zhang L, Poorbaugh J, Dougan M, Chen P, Gottlieb RL, Huhn G, Beasley S, Daniels M, Ngoc Vy Trinh T, Crisp M, Freitas JJ, Vaillancourt P, Patel DR, Nirula A, Kallewaard NL, Higgs RE, Benschop RJ. Zhang L, et al. Among authors: dougan m. Front Immunol. 2021 Dec 9;12:790469. doi: 10.3389/fimmu.2021.790469. eCollection 2021. Front Immunol. 2021. PMID: 34956222 Free PMC article. Clinical Trial.

7

Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint Therapy.

Falade AS, Reynolds KL, Zubiri L, Deshpande V, Fintelmann FJ, Dougan M, Mooradian MJ. Falade AS, et al. Among authors: dougan m. Front Immunol. 2022 Apr 14;13:871452. doi: 10.3389/fimmu.2022.871452. eCollection 2022. Front Immunol. 2022. PMID: 35493494 Free PMC article.

8

Human differentiated eosinophils release IL-13 in response to IL-33 stimulation.

Uchida AM, Ro G, Qiang L, Peterson KA, Round J, Dougan M, Dougan SK. Uchida AM, et al. Among authors: dougan sk, dougan m. Front Immunol. 2022 Sep 13;13:946643. doi: 10.3389/fimmu.2022.946643. eCollection 2022. Front Immunol. 2022. PMID: 36177009 Free PMC article.

9

Update on Immune Checkpoint Inhibitor Enterocolitis.

Kelly-Goss MR, Badran YR, Dougan M. Kelly-Goss MR, et al. Among authors: dougan m. Curr Gastroenterol Rep. 2022 Dec;24(12):171-181. doi: 10.1007/s11894-022-00852-7. Epub 2022 Oct 20. Curr Gastroenterol Rep. 2022. PMID: 36264425 Free PMC article. Review.

10

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders.

Lazarus HM, Pitts K, Wang T, Lee E, Buchbinder E, Dougan M, Armstrong DG, Paine R 3rd, Ragsdale CE, Boyd T, Rock EP, Gale RP. Lazarus HM, et al. Among authors: dougan m. Front Immunol. 2023 Jan 5;13:1069444. doi: 10.3389/fimmu.2022.1069444. eCollection 2022. Front Immunol. 2023. PMID: 36685591 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters